THE VAN ANDEL INSTITUTE announced the establishment of a global epigenetics research hub.
NEOGENOMICS INC. launched a series of NeoTYPE cancer profiling tests covering 22 different categories of cancer.
MYLAN INC. and its subsidiary, Mylan Pharmaceuticals Private Limited, launched the world's first Herceptin biosimilar in India.
ION SOLUTIONS selected Foundation Medicine as its preferred partner for comprehensive cancer genomic profiling services.
Twenty-six public health and medical organizations called on drug stores and other retailers to follow the example of CVS Caremark and end the sale of cigarettes and other tobacco products.
GRU CANCER CENTER received a commitment of $6 million from the Masters Tournament and Augusta National Golf Club through the Community Foundation for the Central Savannah River Area.
JENNIFER DOUDNA was named the winner of the Lurie Prize in the Biomedical Sciences by the Foundation for the NIH.
The contractor running the Frederick National Laboratory for Cancer Research received nearly $300 million from NCI in the 2013 fiscal year, and is slated for an increase, officials said at a recent advisory committee meeting.
The 10th annual ST. JUDE THANKS AND GIVING CAMPAIGN raised more than $97 million last holiday season to support the St. Jude Children's Research Hospital, a projected increase of more than 31 percent over the previous year. Since 2004, the campaign has raised nearly $485 million.
NOVARTIS acquired CoStim Pharmaceuticals Inc., a portfolio company developing monoclonal antibody drugs, for an undisclosed amount. The acquisition was announced by MPM Capital and Atlas Venture.
